| 英文名称 |
中文名称 |
CAS |
|
Esomeprazole EP Impurity E
|
埃索美拉唑氮氧化物 |
176219-04-8 |
|
tert-butyl (6S)-7-cyano-6-methyl-8-oxo-5-azaspiro[2.5]octane-5-carboxylate
|
|
3084715-64-7 |
|
Adapalene EP Impurity B
|
阿达帕林EP杂质B |
1346599-76-5 |
|
Rivaroxaban Imp VII-Chiral isomers
|
利伐沙班杂质VII-手性异构体 |
865479-71-6 |
|
Apixaban Impurity BMS-728626
|
阿哌沙班杂质BMS-728626 |
1686149-74-5 |
|
Amorolfine EP Impurity B
|
阿莫罗芬EP杂质B |
142347-84-0 |
|
Apixaban Impurity BMS-778960
|
阿哌沙班杂质BMS-778960 |
2098457-92-0 |
|
Cefalexin EP Impurity B
|
脱乙酰7-ACA |
51500-15-3 |
|
Acetaminophen Impurity 38
|
|
2575516-61-7 |
|
Cefcapene Pivoxil Impurity 17
|
头孢卡品酯酯型二聚体 |
3025716-46-2 |
|
Azilsartan Impurity G
|
阿齐沙坦杂质G |
1403474-70-3 |
|
Bortezomib(1S,2S)isomer
|
硼替佐米(1S,2S)异构体 |
1132709-14-8 |
|
Linezolid Impurity D HCl
|
利奈唑胺杂质D盐酸盐 |
1391068-25-9 |
|
Rivaroxaban Imp III
|
利伐沙班杂质III |
1415566-28-7 |
|
Rivaroxaban Impurity 4
|
利伐沙班杂质4 |
1429334-00-8 |
|
Rivaroxaban Diamine Impurity
|
利伐沙班二胺杂质 |
1807455-76-0 |
|
Mirogabalin Impurity 25
|
|
1235479-60-3 |
|
S-Amlodipine Benzenesulfonate
|
S-氨氯地平苯磺酸盐 |
150566-71-5 |
|
Isavuconazole Impurity 39
|
艾沙康唑杂质39 |
2832083-17-5 |
|
Salbutamol Glyoxal Impurity
|
沙丁胺醇乙二醛杂质 |
|
|
Vildagliptin Imp B
|
维格列汀杂质B |
1036959-23-5 |
|
Risperidone Impurity 14
|
双环利培酮 |
2231638-02-9 |
|
Febuxostat Related Compound B
|
非布司他相关物质B |
1530308-87-2 |
|
Mupirocin EP Impurity C
|
莫匹罗星EP杂质C |
85248-93-7 |
|
Tigecycline EP Impurity A
|
替加环素EP杂质A |
1422262-97-2 |
|
Brivaracetam Impurity 24
|
布立西坦中间体1 |
1942054-60-5 |
|
Nimodipine Impurity 5
|
methyl 5-methyl-3'-nitro-3-oxo-1,2,3,6-tetrahydro-[1,1'-biphenyl]-2-carboxylate |
2469735-68-8 |
|
Doxycycline Hyclate EP Impurity C
|
盐酸强力霉素EP杂质C |
6543-77-7 |
|
Apixaban Impurity BMS-589154
|
阿哌沙班杂质BMS-589154 |
503614-91-3 |
|
Tobramycin EP Impurity A
|
妥布霉素A |
20744-51-8 |
|
Tacrolimus Impurity 2
|
他克莫司杂质XI |
131944-48-4 |
|
Bortezomib Impurity 22(S,R-Isomer)
|
硼替佐米杂质22（S,R-异构体） |
289472-78-2 |
|
Apixaban Impurity BMS-719288
|
阿哌沙班杂质BMS-719288 |
1074365-84-6 |
|
Febuxostat Related Compound A
|
非布司他相关化合物A |
1239233-86-3 |
|
Febuxostat Impurity C
|
非布司他杂质C |
1239233-87-4 |
|
Linezolid N-Oxide
|
利奈唑胺氮氧化物 |
189038-36-6 |
|
Vortioxetine Impurity F
|
沃替西汀杂质F |
1429908-35-9 |
|
Cephalothin Impurity B
|
头孢噻吩杂质 |
34691-02-6 |
|
Cholecalciferol EP Impurity E
|
胆钙化醇EP杂质E |
17592-07-3 |
|
Cyclophosphamide Impurity
35
|
|
67856-68-2 |
|
Vildagliptin Impurity C
|
维格列汀杂质C |
565453-40-9 |
|
Tacrolimus Lactone Isomer
|
他克莫司内酯异构体 |
134590-88-8 |
|
Rivaroxaban Imp II
|
利伐沙班杂质II |
1365267-35-1 |
|
Mirogabalin Impurity 17
|
|
1138245-15-4 |
|
Nimodipine Impurity 55
|
methyl 2-acetyl-3-(3-nitrophenyl)-5-oxohexanoate |
2469555-30-2 |
|
Empagliflozin Impurity POE
|
恩格列净杂质POE |
2452301-14-1 |
|
Lactulose EP Impurity F
|
乳果糖杂质F |
136272-61-2 |
|
Dapagliflozin Impurity POE
|
达格列净杂质22 |
2452300-94-4 |
|
Omeprazole EP Impurity C
|
奥美拉唑EP杂质C |
73590-85-9 |
|
Apixaban
|
阿哌沙班 |
503612-47-3 |
|
|
阿维巴坦亚硝胺杂质4 |
|
|
Oxaliplatin EP Impurity E
|
奥沙利铂EP杂质E |
82398-34-3 |
|
Nimodipine Impurity 3
|
methyl 3-methyl-3'-nitro-5-oxo-1,2,5,6-tetrahydro-[1,1'-biphenyl]-2-carboxylate |
87625-92-1 |
|
Bortezomib Impurity F
|
硼替佐米杂质F |
73058-37-4 |
|
Tacrolimus EP Impurity H
|
他克莫司EP杂质H |
143210-33-7 |
|
Nimodipine Impurity 7
|
5-(methoxycarbonyl)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3-carboxylic acid |
74936-72-4 |
|
Lansoprazole EP Impurity A
|
兰索拉唑EP杂质A |
213476-12-1 |
|
(1R,2R)-Bortezomib Impurity
|
(1R,2R)-硼替佐米杂质 |
1132709-15-9 |
|
Bortezomib Impurity 41
|
硼替佐米杂质41 |
289472-80-6 |
|
Fluoxetine EP Impurity A(Atomoxetine EP Impurity H)
|
氟西汀EP杂质A（阿托莫西汀EP杂质H） |
42142-52-9 |
|
Rivaroxaban Impurity 5
|
利伐沙班杂质5 |
86427-02-3 |
|
Hydrochlorothiazide EP Impurity C
|
氢氯噻嗪EP杂质C |
402824-96-8 |
|
Isavuconazole Impurity 31
|
艾沙康唑杂质31 |
2761502-58-1 |
|
Cis-Vitamin K1
|
维生素K1顺式异构体 |
16033-41-3 |
|
Linezolid Impurity 1
|
利奈唑胺杂质1 |
333753-67-6 |
|
Bicyclo[2.2.2]octane-1,4-diamine
|
|
1659-77-4 |
|
Apixaban Impurity BMS-724914
|
阿哌沙班杂质BMS-724914 |
2187409-01-2 |
|
Rivaroxaban Imp IV
|
利伐沙班杂质IV |
1770812-37-7 |
|
Amlodipine N-Lactoside
|
氨氯地平N-乳糖 |
749864-27-5 |
|
Fmoc-L-(4,4-difluorocyclohexyl)glycine
|
|
2248184-59-8 |
|
Tacrolimus EP Impurity E
|
他克莫司EP杂质E |
104987-30-6 |
|
Apixaban Impurity BMS-591455
|
阿哌沙班杂质BMS-591455 |
503614-92-4 |
|
Tacrolimus Impurity 6
|
他克莫司杂质6 |
123719-19-7 |
|
Olmesartan Dimer Ester Impurity
|
奥美沙坦二聚体杂质 |
1040250-19-8 |
|
Vildagliptin Imp E
|
维格列汀杂质E |
|
|
Pramipexole Impurity C
|
普拉克索EP杂质C |
1973461-14-1 |
|
Amlodipine Lactose Adduct
|
氨氯地平乳糖加和物 |
2173291-00-2 |
|
(2S,5R)-1-Fmoc-5-methylpiperidine-2-carboxylic acid
|
|
2227864-52-8 |
|
L-Proline, 2-ethyl-, hydrobromide
|
|
161564-05-2 |
|
Mirogabalin Impurity 14
|
|
2166206-19-3 |
|
Rivaroxaban Imp VI
|
利伐沙班杂质VI |
446292-08-6 |
|
Sorafenib
|
索拉非尼 |
284461-73-0 |
|
Rivaroxaban Imp V
|
利伐沙班杂质V |
1365267-36-2 |
|
Vildagliptin Imp A((R)-Vildagliptin)
|
维格列汀杂质A（(R)-维格列汀） |
1036959-27-9 |
|
Vildagliptin Imp D
|
维格列汀杂质D |
565453-39-6 |
|
Omeprazole EP Impurity A
|
奥美拉唑EP杂质A |
37052-78-1 |
|
Carbamic acid, [4-(aminocarbonyl)bicyclo[2.2.2]oct-1-yl]-, phenylmethyl ester
|
|
863303-83-7 |
